{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:49:13Z","timestamp":1790873353326,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170519"],"award-info":[{"award-number":["82170519"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020084","name":"Guangzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["2023A04J1874"],"award-info":[{"award-number":["2023A04J1874"]}],"id":[{"id":"10.13039\/501100020084","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020084","name":"Guangzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["2024A03J1006"],"award-info":[{"award-number":["2024A03J1006"]}],"id":[{"id":"10.13039\/501100020084","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020084","name":"Guangzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["202201020636"],"award-info":[{"award-number":["202201020636"]}],"id":[{"id":"10.13039\/501100020084","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017696","name":"Guangzhou Women and Childrens Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017696","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009659","name":"Guangzhou Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ahj.2024.03.010","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T02:18:27Z","timestamp":1710814707000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Different dose aspirin plus immunoglobulin (DAPI) for prevention of coronary artery abnormalities in Kawasaki disease: Study protocol for a multi-center, prospective, randomized, open-label, blinded end-point, non-inferiority trial"],"prefix":"10.1016","volume":"273","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2260-0790","authenticated-orcid":false,"given":"Yujian","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengxiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuliang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8783-8890","authenticated-orcid":false,"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2024.03.010_bib0001","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(04)16814-1","article-title":"Kawasaki syndrome","volume":"364","author":"Burns","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2024.03.010_bib0002","first-page":"178","article-title":"Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children","volume":"16","author":"Kawasaki","year":"1967","journal-title":"Arerugi"},{"key":"10.1016\/j.ahj.2024.03.010_bib0003","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.jacc.2009.04.102","article-title":"When children with Kawasaki disease grow up: myocardial and vascular complications in adulthood","volume":"54","author":"Gordon","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2024.03.010_bib0004","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1056\/NEJM198704023161415","article-title":"Treatment of Kawasaki syndrome with intravenous gamma globulin","volume":"316","author":"Murphy","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2024.03.010_bib0005","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0140-6736(84)91504-6","article-title":"High-dose intravenous gammaglobulin for Kawasaki disease","volume":"2","author":"Furusho","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2024.03.010_bib0006","doi-asserted-by":"crossref","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of Kawasaki Disease: a scientific statement for health professionals from the American Heart Association","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2024.03.010_bib0007","article-title":"Intravenous immunoglobulin for the treatment of Kawasaki disease","volume":"1","author":"Broderick","year":"2023","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.ahj.2024.03.010_bib0008","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1056\/NEJM199106063242305","article-title":"A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome","volume":"324","author":"Newburger","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2024.03.010_bib0009","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1001\/jama.1985.03360060069027","article-title":"Probable efficacy of high-dose salicylates in reducing coronary involvement in Kawasaki disease","volume":"254","author":"Koren","year":"1985","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2024.03.010_bib0010","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0022-3476(97)70038-6","article-title":"Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose","volume":"131","author":"Terai","year":"1997","journal-title":"J Pediatr"},{"key":"10.1016\/j.ahj.2024.03.010_bib0011","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/archdischild-2019-318245","article-title":"Low-dose or no aspirin administration in acute-phase Kawasaki disease: a meta-analysis and systematic review","volume":"106","author":"Chiang","year":"2021","journal-title":"Arch Dis Child."},{"key":"10.1016\/j.ahj.2024.03.010_bib0012","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1542\/peds.96.6.1057","article-title":"The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment","volume":"96","author":"Durongpisitkul","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.ahj.2024.03.010_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.725126","article-title":"Treatment of Kawasaki disease: a network meta-analysis of four dosage regimens of aspirin combined with recommended intravenous immunoglobulin","volume":"12","author":"Huang","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ahj.2024.03.010_bib0014","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/rheumatology\/keaa050","article-title":"What dose of aspirin should be used in the initial treatment of Kawasaki disease? A meta-analysis","volume":"59","author":"Jia","year":"2020","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.ahj.2024.03.010_bib0015","doi-asserted-by":"crossref","first-page":"e689","DOI":"10.1542\/peds.2004-1037","article-title":"Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited","volume":"114","author":"Hsieh","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.ahj.2024.03.010_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144603","article-title":"High-dose aspirin is associated with anemia and does not confer benefit to disease outcomes in Kawasaki disease","volume":"10","author":"Kuo","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ahj.2024.03.010_bib0017","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0022-3476(96)80140-5","article-title":"Gastrointestinal hemorrhage complicating aspirin therapy in acute Kawasaki disease","volume":"128","author":"Matsubara","year":"1996","journal-title":"J Pediatr"},{"key":"10.1016\/j.ahj.2024.03.010_bib0018","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10238-019-00596-1","article-title":"Hepatic dysfunction secondary to Kawasaki disease: characteristics, etiology and predictive role in coronary artery abnormalities","volume":"20","author":"Mammadov","year":"2020","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.ahj.2024.03.010_bib0019","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/jpc.13816","article-title":"Is aspirin necessary in the acute phase of Kawasaki disease?","volume":"54","author":"Huang","year":"2018","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.ahj.2024.03.010_bib0020","doi-asserted-by":"crossref","DOI":"10.1177\/2050312120974176","article-title":"Assessment of Reye's syndrome profile with data from the US Food and Drug Administration Adverse Event Reporting System and the Japanese Adverse Drug Event Report databases using the disproportionality analysis","volume":"8","author":"Matsumoto","year":"2020","journal-title":"SAGE Open Med"},{"key":"10.1016\/j.ahj.2024.03.010_bib0021","article-title":"Kawasaki disease and allergic diseases","volume":"8","author":"Huang","year":"2020","journal-title":"Front Pediatr."},{"key":"10.1016\/j.ahj.2024.03.010_bib0022","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jaip.2014.09.009","article-title":"Aspirin or other nonsteroidal inflammatory agent exacerbated asthma","volume":"2","author":"Ledford","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.ahj.2024.03.010_bib0023","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/sim.4780010412","article-title":"The role of randomization in clinical trials","volume":"1","author":"Armitage","year":"1982","journal-title":"Stat Med."},{"key":"10.1016\/j.ahj.2024.03.010_bib0024","doi-asserted-by":"crossref","first-page":"c869","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Moher","year":"2010","journal-title":"Bmj"},{"key":"10.1016\/j.ahj.2024.03.010_bib0025","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(02)07750-4","article-title":"Allocation concealment in randomised trials: defending against deciphering","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2024.03.010_bib0026","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.echo.2006.09.001","article-title":"Guidelines and standards for performance of a pediatric echocardiogram: a report from the Task Force of the Pediatric Council of the American Society of Echocardiography","volume":"19","author":"Lai","year":"2006","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.ahj.2024.03.010_bib0027","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/01.CIR.58.6.1072","article-title":"Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements","volume":"58","author":"Sahn","year":"1978","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2024.03.010_bib0028","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.echo.2010.03.019","article-title":"Recommendations for quantification methods during the performance of a pediatric echocardiogram: a report from the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council","volume":"23","author":"Lopez","year":"2010","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.ahj.2024.03.010_bib0029","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/cei.13010","article-title":"Arterial immune protein expression demonstrates the complexity of immune responses in Kawasaki disease arteritis","volume":"190","author":"Cameron","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ahj.2024.03.010_bib0030","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1086\/323155","article-title":"CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease","volume":"184","author":"Brown","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ahj.2024.03.010_bib0031","doi-asserted-by":"crossref","first-page":"5946","DOI":"10.4049\/jimmunol.159.12.5946","article-title":"IgA plasma cells in vascular tissue of patients with Kawasaki syndrome","volume":"159","author":"Rowley","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.ahj.2024.03.010_bib0032","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-0098","article-title":"Aspirin dose and prevention of coronary abnormalities in Kawasaki disease","volume":"139","author":"Dallaire","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.ahj.2024.03.010_bib0033","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00431-023-05302-8","article-title":"Association between aspirin dose and outcomes in patients with acute Kawasaki disease: a nationwide retrospective cohort study in Japan","volume":"183","author":"Suzuki","year":"2024","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.ahj.2024.03.010_bib0034","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/01.CIR.0000145143.19711.78","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association","volume":"110","author":"Newburger","year":"2004","journal-title":"Circulation."},{"key":"10.1016\/j.ahj.2024.03.010_bib0035","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/01.CIR.87.5.1776","article-title":"Diagnosis and therapy of Kawasaki disease in children","volume":"87","author":"Dajani","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2024.03.010_bib0036","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1097\/INF.0000000000003974","article-title":"Overview of guidelines for the medical treatment of acute Kawasaki Disease in Japan (2020 Revised Version) and positioning of plasma exchange therapy in the acute phase","volume":"42","author":"Mori","year":"2023","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ahj.2024.03.010_bib0037","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/ped.12317","article-title":"Guidelines for medical treatment of acute Kawasaki disease: report of the Research Committee of the Japanese Society of Pediatric Cardiology and Cardiac Surgery (2012 revised version)","volume":"56","year":"2014","journal-title":"Pediatr Int"},{"key":"10.1016\/j.ahj.2024.03.010_bib0038","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1253\/circj.CJ-19-1094","article-title":"JCS\/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease","volume":"84","author":"Fukazawa","year":"2020","journal-title":"Circ J"},{"key":"10.1016\/j.ahj.2024.03.010_bib0039","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13052-021-00962-4","article-title":"Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease","volume":"47","author":"Marchesi","year":"2021","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.ahj.2024.03.010_bib0040","article-title":"Anti-inflammatory treatment of Kawasaki Disease: comparison of current guidelines and perspectives","volume":"8","author":"Buda","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ahj.2024.03.010_bib0041","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10555-017-9675-z","article-title":"Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention","volume":"36","author":"Ornelas","year":"2017","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.ahj.2024.03.010_bib0042","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1073\/pnas.72.8.3073","article-title":"Acetylation of prostaglandin synthase by aspirin","volume":"72","author":"Roth","year":"1975","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.ahj.2024.03.010_bib0043","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.pharmtox.38.1.97","article-title":"Cyclooxygenases 1 and 2","volume":"38","author":"Vane","year":"1998","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.ahj.2024.03.010_bib0044","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0022-3476(05)82168-7","article-title":"Decreased protein binding of salicylates in Kawasaki disease","volume":"118","author":"Koren","year":"1991","journal-title":"J Pediatr"},{"key":"10.1016\/j.ahj.2024.03.010_bib0045","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0022-3476(88)80194-X","article-title":"Determinants of low serum concentrations of salicylates in patients with Kawasaki disease","volume":"112","author":"Koren","year":"1988","journal-title":"J Pediatr"},{"key":"10.1016\/j.ahj.2024.03.010_bib0046","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/0194599814553930","article-title":"Ubiquitous aspirin: a systematic review of its impact on sensorineural hearing loss","volume":"152","author":"Kyle","year":"2015","journal-title":"Otolaryngol Head Neck Surg."},{"key":"10.1016\/j.ahj.2024.03.010_bib0047","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1440-1754.2005.00617.x","article-title":"Reye's syndrome developing in an infant on treatment of Kawasaki syndrome","volume":"41","author":"Wei","year":"2005","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.ahj.2024.03.010_bib0048","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s40272-022-00514-1","article-title":"Efficacy and safety of NSAIDs in infants: a comprehensive review of the literature of the past 20 years","volume":"24","author":"Ziesenitz","year":"2022","journal-title":"Paediatr Drugs."},{"key":"10.1016\/j.ahj.2024.03.010_bib0049","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0022-3476(05)83556-5","article-title":"Identification of nonsteroidal anti-inflammatory drug-induced gastroduodenal injury in children with juvenile rheumatoid arthritis","volume":"122","author":"Mulberg","year":"1993","journal-title":"J Pediatr"},{"key":"10.1016\/j.ahj.2024.03.010_bib0050","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/acr.24838","article-title":"2021 American College of rheumatology\/vasculitis foundation guideline for the management of Kawasaki Disease","volume":"74","author":"Gorelik","year":"2022","journal-title":"Arthritis Care Res (Hoboken)."}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870324000711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870324000711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T02:36:32Z","timestamp":1721356592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870324000711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":50,"alternative-id":["S0002870324000711"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2024.03.010","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Different dose aspirin plus immunoglobulin (DAPI) for prevention of coronary artery abnormalities in Kawasaki disease: Study protocol for a multi-center, prospective, randomized, open-label, blinded end-point, non-inferiority trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2024.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}